title: [Hormonal replacement therapy by patientsafter treatment for gynecological cancer].
abstract: OBJECTIVE
  The most of gynecological cancers are diagnosed in postmenopausal period. There are, however, part of the premenopausal women which occurs to develop vegetative problems after medical procedures. The aim of the study is to provide an overview of the current status and views on hormone replacement therapy in women after treatment for gynecologic malignancy.
  
  
  METHODS
  Systematic review.
  
  
  METHODS
  Current literature review.
  
  
  CONCLUSIONS
  The available literature sources don't show that hormone replacement therapy for premenopausal women worsens the prognosis of the underlying disease after treatment of gynecological cancer. The limiting factor in most of the works are small groups of patients and the low stage of disease at enrollment (especially for endometrial cancer). Even though no study has shown worsening prognosis or shorter disease free interval. However, it is necessary to proceed individually for each patient with an evaluation of the current status and potential benefits that this treatment can get.
authors: P
authors: P
authors: Havelka
authors: V
authors: V
authors: Kalist
authors: Z
authors: Z
authors: Adamík
mesh_terms: D016889:Endometrial Neoplasms / Q000628:therapy*; D005260:Female; D020249:Hormone Replacement Therapy / Q000379:methods*; D006801:Humans; D010360:Patient Transfer / Q000379:methods*; D017698:Postmenopause